Asia Agenda

CSAs come of age in Asia

While commission sharing agreements (CSA) and the unbundling of commission and research payments from investors still have a long way to go in Asia – and are not mandated anywhere in the region yet – the concept is beginning to gain some traction in the region. Meanwhile, the cost-cutting that is pushing down commissions across the board should actually provide a boost to good quality independent research providers as fund managers feel the pressure to make their shrinking budgets work more efficiently than ever. 

“The view that you can purchase your research in one place and pay for that via where you feel you’re getting best execution is gaining ground as a concept in Asia,” says Peter Twist, CEO of commission management platform provider IND-X Securities, which announced its takeover of Asian independent research firm Enzard this month. “There is huge scope for unbundling in Asia.”

However, regulators in some markets in Asia don’t allow commission sharing to take place, let alone require it, as is the case in Europe and the US, points out Edward Stockreisser, head of Asia Pacific at Lombard Street Research and co-chair of the Association of Asian Independent Research Providers (Asia IRP).

Nevertheless, Twist believes the situation is moving in the right direction.

“I believe regulators across the board do think that pursuing best execution, whatever that means to a particular manager, and being able to maximise returns by potentially looking at alternative sources of research and not necessarily having a trading relationship with the supplier of that research, is fundamentally a decent concept,” suggests Twist.

“The specific benefit for the buy-side is that they are free to go and search for what, in their view, is the best research and the best execution,” says Twist. “Unbundling really does level the playing field.”

Twist points out fund managers often have four or five brokers which they are tied to because they have paid research relationships with them: “What you can do is strike four of them off your list, add one CSA broker and reward them through there. Streamline your operations.”

The financial crisis actually helped develop the independent research space in two ways, argues Stockreisser. The lack of proper coverage being provided to smaller funds by banks since the crisis has increased the appeal of the smaller research firms, which themselves have been boosted in number following the exoduses of researchers from the big banks to launch their own outfits in the aftermath of the credit crunch.

With commissions down as much as 50% in a lot of markets, competition amongst the expanded independent provider sector is also heating up and a phase of consolidation may be on the cards.

Research being ‘conflict-free’ doesn’t automatically make it better, and the smaller houses have to stand or fall on the merits of their output.

“If independent research isn’t of good quality, nobody is going to buy it, unlike bulge bracket houses which may have poor research but because of the full service products they offer, will still get paid,” says Twist, who makes the point that bigger doesn’t necessarily mean worse either.

“When separating the commission dollars from your execution dollars, there’s no reason why you can’t unbundle one of the bulge bracket brokers, you might decide that Goldman Sachs’ research is the best out there,” he adds.

“There is likely to be a shift in emphasis to quality rather just whether research is independent or not,” says Stockreisser. “The ultimate issue is that nobody really cares if research is independent or not, as long as it’s good.” 

Gavin Blair